Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2020

31.07.2019 | Original Article

Chyme Reinfusion Is Associated with Lower Rate of Postoperative Ileus in Crohn’s Disease Patients After Stoma Closure

verfasst von: Ming Duan, Lei Cao, Lei Gao, Jianfeng Gong, Yi Li, Weiming Zhu

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The rate of postoperative ileus following stoma closure is high in patients with Crohn’s disease and temporary enterostomy.

Aims

To evaluate the effect of chyme reinfusion on postoperative outcomes including ileus in these patients.

Methods

Patients were screened from January 2012 to December 2017 and divided into chyme reinfusion group (n = 33) and non-chyme reinfusion group (n = 84). The following 30-day postoperative outcomes were evaluated. Univariate and multivariate analyses and propensity score matching were performed to identify risk factors for these postoperative outcomes.

Results

The incidence of postoperative ileus was significantly lower in the chyme reinfusion than in non-chyme reinfusion group, which had been confirmed by the results after matching (3/26 vs 11/26, p = 0.012). The rate of postoperative diarrhea was significantly lower in the chyme reinfusion group compared with non-chyme reinfusion group, whereas the difference was not significant after matching (2/26 vs 6/26, p = 0.191). Additionally, the postoperative length of stay was significantly shorter in the chyme reinfusion than in non-chyme reinfusion group before and after propensity score matching. In the multivariate analysis, chyme reinfusion was an independent protective factor for postoperative ileus (odds ratio 0.218; 95% confidence interval 0.05–0.95; p = 0.042) and for postoperative length of stay (coefficient − 0.191; 95% confidence interval − 0.350 to − 0.032, p = 0.019).

Conclusions

Chyme reinfusion was associated with lower rate of postoperative ileus and shorter length of stay following stoma closure in Crohn’s patients with temporary ileostomy. Further randomized clinical trial between patients with or without chyme reinfusion was needed to confirm these conclusions.
Literatur
1.
Zurück zum Zitat Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Diseases Colon Rectum. 2007;50:331–336.CrossRef Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Diseases Colon Rectum. 2007;50:331–336.CrossRef
3.
Zurück zum Zitat Morar PS, Hodgkinson JD, Thalayasingam S, et al. Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn’s disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohns Colitis. 2015;9:483–491. https://doi.org/10.1093/ecco-jcc/jjv051.CrossRefPubMed Morar PS, Hodgkinson JD, Thalayasingam S, et al. Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn’s disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohns Colitis. 2015;9:483–491. https://​doi.​org/​10.​1093/​ecco-jcc/​jjv051.CrossRefPubMed
5.
Zurück zum Zitat Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12:1–16.CrossRef Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12:1–16.CrossRef
10.
Zurück zum Zitat Ekelund KM, Ekblad E. Structural, neuronal, and functional adaptive changes in atrophic rat ileum. Gut. 1999;45:236–245.CrossRef Ekelund KM, Ekblad E. Structural, neuronal, and functional adaptive changes in atrophic rat ileum. Gut. 1999;45:236–245.CrossRef
12.
Zurück zum Zitat Miedema BW, Karlstrom L, Hanson RB, Johnson GP, Kelly KA. Absorption and motility of the bypassed human ileum. Diseases Colon Rectum. 1990;33:829–835.CrossRef Miedema BW, Karlstrom L, Hanson RB, Johnson GP, Kelly KA. Absorption and motility of the bypassed human ileum. Diseases Colon Rectum. 1990;33:829–835.CrossRef
14.
Zurück zum Zitat Levy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg. 1989;76:676–679.CrossRef Levy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg. 1989;76:676–679.CrossRef
15.
Zurück zum Zitat Picot D, Layec S, Dussaulx L, Trivin F, Thibault R. Chyme reinfusion in patients with intestinal failure due to temporary double enterostomy: a 15-year prospective cohort in a referral centre. Clin Nutr. 2017;36:593–600.CrossRef Picot D, Layec S, Dussaulx L, Trivin F, Thibault R. Chyme reinfusion in patients with intestinal failure due to temporary double enterostomy: a 15-year prospective cohort in a referral centre. Clin Nutr. 2017;36:593–600.CrossRef
16.
Zurück zum Zitat Price AB, Morson BC. Inflammatory bowel disease: the surgical pathology of Crohn’s disease and ulcerative colitis. Hum Pathol. 1975;6:7–29.CrossRef Price AB, Morson BC. Inflammatory bowel disease: the surgical pathology of Crohn’s disease and ulcerative colitis. Hum Pathol. 1975;6:7–29.CrossRef
17.
Zurück zum Zitat Rychter J, Clavé P. Intestinal inflammation in postoperative ileus: pathogenesis and therapeutic targets. Gut. 2013;62:1534–1535.CrossRef Rychter J, Clavé P. Intestinal inflammation in postoperative ileus: pathogenesis and therapeutic targets. Gut. 2013;62:1534–1535.CrossRef
18.
Zurück zum Zitat Gaertner WB, Madoff RD, Mellgren A, Kwaan MR, Melton GB. Postoperative diarrhea and high ostomy output impact postoperative outcomes after elective colon and rectal operations regardless of Clostridium difficile infection. Am J Surg. 2015;210:759–765.CrossRef Gaertner WB, Madoff RD, Mellgren A, Kwaan MR, Melton GB. Postoperative diarrhea and high ostomy output impact postoperative outcomes after elective colon and rectal operations regardless of Clostridium difficile infection. Am J Surg. 2015;210:759–765.CrossRef
19.
Zurück zum Zitat Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–278.CrossRef Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–278.CrossRef
Metadaten
Titel
Chyme Reinfusion Is Associated with Lower Rate of Postoperative Ileus in Crohn’s Disease Patients After Stoma Closure
verfasst von
Ming Duan
Lei Cao
Lei Gao
Jianfeng Gong
Yi Li
Weiming Zhu
Publikationsdatum
31.07.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05753-w

Weitere Artikel der Ausgabe 1/2020

Digestive Diseases and Sciences 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.